Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of ZIM LABORATORIES. For more details, see the ZIM LABORATORIES quarterly results and ZIM LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 8.8 |
No. of shares | m | 48.73 |
1 Week | % | 26.4 |
1 Month | % | 24.9 |
1 Year | % | 55.0 |
52 week H/L | Rs | 151.8/74.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ZIM LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 480 | 149 | 131 | 189 | 388 | |
Low | Rs | 117 | 42 | 53 | 70 | 67 | |
Sales per share (Unadj.) | Rs | 208.0 | 171.7 | 189.2 | 205.3 | 81.8 | |
Earnings per share (Unadj.) | Rs | 9.5 | 2.0 | 4.5 | 9.0 | 5.0 | |
Diluted earnings per share | Rs | 3.1 | 0.7 | 1.5 | 3.0 | 5.0 | |
Cash flow per share (Unadj.) | Rs | 16.6 | 10.9 | 14.2 | 18.8 | 8.6 | |
Dividends per share (Unadj.) | Rs | 0.50 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.2 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 93.0 | 94.8 | 99.0 | 108.2 | 41.1 | |
Adj. book value per share | Rs | 30.8 | 31.5 | 33.0 | 36.1 | 41.1 | |
Shares outstanding (eoy) | m | 16.12 | 16.18 | 16.24 | 16.24 | 48.73 | |
Price / Sales ratio | x | 1.4 | 0.6 | 0.5 | 0.6 | 2.8 | |
Avg P/E ratio | x | 31.4 | 46.9 | 20.5 | 14.5 | 45.4 | |
P/CF ratio (eoy) | x | 18.0 | 8.7 | 6.5 | 6.9 | 26.5 | |
Price / Book Value ratio | x | 3.2 | 1.0 | 0.9 | 1.2 | 5.5 | |
Dividend payout | % | 5.3 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 4,814 | 1,544 | 1,497 | 2,108 | 11,096 | |
Total wages/salary | Rs m | 483 | 353 | 358 | 401 | 493 |
ZIM LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,354 | 2,777 | 3,073 | 3,334 | 3,985 | |
Other income | Rs m | 20 | 45 | 23 | 44 | 64 | |
Total revenues | Rs m | 3,374 | 2,823 | 3,096 | 3,378 | 4,049 | |
Gross profit | Rs m | 420 | 226 | 346 | 410 | 520 | |
Depreciation | Rs m | 114 | 144 | 158 | 160 | 175 | |
Interest | Rs m | 106 | 127 | 109 | 83 | 56 | |
Profit before tax | Rs m | 221 | 1 | 102 | 210 | 354 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 67 | -32 | 29 | 65 | 109 | |
Profit after tax | Rs m | 153 | 33 | 73 | 146 | 244 | |
Gross profit margin | % | 12.5 | 8.1 | 11.3 | 12.3 | 13.0 | |
Effective tax rate | % | 30.5 | -4,678.3 | 28.5 | 30.9 | 30.9 | |
Net profit margin | % | 4.6 | 1.2 | 2.4 | 4.4 | 6.1 |
ZIM LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,953 | 1,820 | 1,918 | 2,136 | 1,909 | |
Current liabilities | Rs m | 1,564 | 1,434 | 1,420 | 1,474 | 1,108 | |
Net working cap to sales | % | 11.6 | 13.9 | 16.2 | 19.9 | 20.1 | |
Current ratio | x | 1.2 | 1.3 | 1.4 | 1.4 | 1.7 | |
Inventory Days | Days | 14 | 16 | 16 | 13 | 19 | |
Debtors Days | Days | 1,013 | 893 | 858 | 980 | 872 | |
Net fixed assets | Rs m | 1,324 | 1,379 | 1,304 | 1,295 | 1,569 | |
Share capital | Rs m | 161 | 162 | 162 | 162 | 487 | |
"Free" reserves | Rs m | 1,338 | 1,373 | 1,445 | 1,595 | 1,516 | |
Net worth | Rs m | 1,499 | 1,535 | 1,608 | 1,757 | 2,003 | |
Long term debt | Rs m | 222 | 274 | 218 | 189 | 246 | |
Total assets | Rs m | 3,277 | 3,200 | 3,222 | 3,431 | 3,479 | |
Interest coverage | x | 3.1 | 1.0 | 1.9 | 3.5 | 7.3 | |
Debt to equity ratio | x | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.0 | 0.9 | 1.0 | 1.0 | 1.1 | |
Return on assets | % | 7.9 | 5.0 | 5.7 | 6.7 | 8.6 | |
Return on equity | % | 10.2 | 2.1 | 4.6 | 8.3 | 12.2 | |
Return on capital | % | 19.0 | 7.0 | 11.6 | 15.1 | 18.2 | |
Exports to sales | % | 62.0 | 57.6 | 67.4 | 75.5 | 81.1 | |
Imports to sales | % | 10.3 | 4.6 | 4.1 | 11.8 | 12.2 | |
Exports (fob) | Rs m | 2,079 | 1,600 | 2,072 | 2,518 | 3,230 | |
Imports (cif) | Rs m | 345 | 128 | 127 | 394 | 485 | |
Fx inflow | Rs m | 2,079 | 1,697 | 2,140 | 2,531 | 3,281 | |
Fx outflow | Rs m | 345 | 128 | 127 | 394 | 485 | |
Net fx | Rs m | 1,734 | 1,569 | 2,012 | 2,137 | 2,796 |
ZIM LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 349 | 219 | 319 | 492 | 375 | |
From Investments | Rs m | -207 | -194 | -59 | -146 | -362 | |
From Financial Activity | Rs m | -152 | -22 | -260 | -330 | 5 | |
Net Cashflow | Rs m | -10 | 10 | -1 | 20 | 30 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Anwar Siraj Daud | COMP SEC: Piyush Siddeshwar Nikhade | YEAR OF INC: 1984 | BSE CODE: 541400 | FV (Rs): 10 | DIV YIELD (%): - |
Read: ZIM LABORATORIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare ZIM LABORATORIES With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.